NUEVOS TÓPICOS DEL EuroPCR 2007

SIMPOSIUM I. EN INTERVENCIÓN PERCUTÁNEA CORONARIA EN FASE AGUDA Y TARDÍA DEL INFARTO

• Introduction and Learning Objectives. Franz Weidinger
• Multivessel Disease in Stemi Undergoing Primary PCI-Evaluation before Further Revascularization. Marko Noc, MD. PhD
• Post-Lytic PCI: is <24 hours a must? Dr. Martin T Rhotman
• Primary Percutaneous Intervention. Witch approach is the best for the culprit lesion? Dr. Harry Suryapranata

SIMPOSIUM II. SEGURIDAD Y EFICACIA DE LOS STENTS LIBERADORES DE DROGA (PARTE I)

• Introducction. Bernhard Meier, MD
• Weight of Evidence for Sirolimus Eluting Stents. Dr. Carlo Di Mario
• Redefinig the consequences of restenosis. Dr. Raúl Moreno
• TAKE HOME MESSAGES

SIMPOSIUM III. SEGURIDAD Y EFICACIA DE LOS STENTS LIBERADORES DE DROGA (PARTE II)

• How to Evaluate DES Safety and Efficacy Including Vasomotion. Alexandre Abizaid, MD. PhD
• DES vs. CABG in Multivessel Disease: Economic Considerations. David J Cohen, MD
• When do I prefer Bare-Metal Stents and When do I prefer Drug Eluting Stent. Practical recomendations. Phillip Urban, MD

SIMPOSIUM DEL TCT

• The case for Coronary Drug Eluting Stents as the Default Choice. Antonio Colombo, MD
• The case for Medical Therapy as the Default Choice. G.B. Jonh Mancini, MD
• "Old" vs "New" Coronary DES: Meaningful Progress or More of the same. Martin B. Leon, MD
• DES Safety and Efficacy: Considerations for on-label and off-label use. Gergg W. Stone, MD
• The Case for selective use of Bare-Metal Stents. William Wijns, MD

TÓPICOS DIVERSOS

• ESC Guidelines for the Management of Non-ST Segment Elevation Acute Coronary Syndromes. Jean Pierre Bassand, MD. FESC
• DES assisted PCI should stillbe the tratment for suitable symptomatic CAD. Keith D. Dawkins
• Increassing Succesful outcomes of CTO; Techniques and tools for 2007. Jacques Koolen MD, PhD
• Clinical Data Update 2007. Lim Soo Teik
• A critical view on the current clinical data: What do we really know? Roxana Mehran, MD
• Techniques for optimising outcomes of chronic total occlusions. Carlos Van Mieghem

ESTUDIOS 

• ESTUDIO REALITY
• ESTUDIO STEEPLE (Seguridad y Eficacio Enoxaparina Intravenosa en intervención Coronaria Percutánea Electiva. Dr. Gilles Montalescot
• OCLUSIÓN TOTAL CRÓNICA. Dr. Charles Simanton
• QUÉ ES LO NUEVO EN INTERVENCIONISMO CORONARIO PARA INJERTOS VENOSOS? Dr. Jonh S. Douglas
• AVANCES TÉCNICOS EN IMPLANTACIÓN DE VÁLVULA AÓRTICA PERCUTÁNEA. Dr. Alain Cribier
• REEMPLAZO VALVULAR PULMONAR. ESTADO DEL ARTE Y DESARROLLO FUTURO. Dr. Sachin Khambadkone